Director of Hematology/Oncology Infectious Diseases
Massachusetts General Hospital
Disclosure(s): Cidara: Grant/Research Support; F2G: Grant/Research Support; GSK: Grant/Research Support; Melinta: Advisor/Consultant; Pfizer: Advisor/Consultant; Roche: Advisor/Consultant; Scynexis: Grant/Research Support; Seres Therapeutics: Advisor/Consultant
Sarah Hammond, MD is an assistant professor at Harvard Medical School in Medicine and is part of the clinical faculty in the Infectious Diseases and Hematology/Oncology Divisions at Massachusetts General Hospital where she is the Director of Hematology/Oncology Infectious Diseases and a consulting physician at the Dana-Farber Cancer Institute both in Boston, Massachusetts, USA. Her clinical research is focused on the prevention and treatment of invasive fungal infections in the high-risk cancer and transplant population and in infectious complications of novel immunomodulatory therapies in patients with hematologic malignancy.